Sequential Adaptive Design Method for Incorporating External Data.

Area of Science:

• Biostatistics
• Clinical Trial Design
• Real-World Data Utilization

Background:

• Increasing availability of external data (real-world data, historical data).
• Need for innovative clinical trial designs, particularly for rare diseases where traditional trials are challenging.
• Interest in integrating external data to enhance traditional clinical trials (TCT).

Purpose of the Study:

• To propose and evaluate a complex innovative design for hybrid studies.
• To incorporate external data into randomized clinical trials to augment the control arm.
• To develop an adaptive strategy for utilizing external data in clinical trials.

Main Methods:

• Sequential adaptive design with multiple interim assessments.
• Inverse Probability Weighted Power Prior (IPW-PP) method for adaptive information borrowing.
• Dynamic adjustment of randomization ratios based on augmented information.
• Extension for interim analyses of early efficacy/futility stopping.

Main Results:

• The proposed sequential adaptive design and IPW-PP method demonstrate desirable properties.
• The approach allows for adaptive borrowing of information from external data, accounting for confounding and heterogeneity.
• Dynamic randomization adjustment can reduce current trial sample sizes.
• Potential for early efficacy/futility stopping reduces ineffective treatment exposure and resource use.

Conclusions:

• The hybrid study design effectively integrates external data into randomized clinical trials.
• The sequential adaptive design with IPW-PP is a robust method for enhancing clinical trial efficiency and ethical considerations.
• This approach offers a promising strategy for rare disease research and other scenarios where TCTs are impractical.